A feasibility study for a randomised controlled trial of transcutaneous posterior tibial nerve stimulation to alleviate stroke-related urinary incontinence
Can electrical stimulation of the leg alleviate bladder problems caused by stroke?
A new way to understand the causes of stroke and treatments using human stem cells
CADASIL is one of the most common genetic causes of stroke and dementia. Currently, there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
A pilot study for developing and evaluating a care pathway for cognitive problems after stroke
A pilot study for developing and evaluating a care pathway for cognitive problems after stroke.
After stroke, some speak in a way which is jumbled up: Is there a way to help them un-jumble their words?
Exploring the causes of ‘jargon speech’ through electrophysiology and using it to help stroke survivors that deal with it.
All Party Parliamentary Group on Stroke Research meeting: UK spend on stroke research
Wednesday 17 December 2014
On 16 December, 2014 the Stroke Association visited the Houses of Parliament to speak to the All Party Parliamentary Group (APPG) on Stroke Research.
Almost half of stroke survivors suffer fatigue, study reveals
Tuesday 7 March 2017
Although stroke survivors have reported fatigue as a problem, previous estimates of the numbers of people affected have varied greatly – from one-quarter to almost three-quarters of stroke survivors.
AMRC - A spotlight on medical health research
Monday 8 May 2017
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.
AMRC's Making a difference: Impact report 2017
Monday 3 July 2017
The Stroke Association is a member of the Association of Medical Research Charities (AMRC), which is the national membership organisation of leading medical and health research charities in the UK. Published today, the AMRC's 'Making a difference: Impact report 2017' highlights how the research of its member charities makes a difference.
An initial evaluation of a new therapy programme which aims to improve arm function after stroke
This project aims to develop and test a repetitive functional task practice (RFTP) therapy programme. Research physiotherapists will develop the programme in conjunction with stroke unit staff and patients.
ATTEST 2: A trial comparing the new “clot busting” drug treatment tenecteplase with standard clot-busting treatment
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.